Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renzo Mignani

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Orphanet Journal of Rare Diseases|April 9, 2020
The GALA project: practical recommendations for the use of migalastat in clinical practice on the basis of a structured survey among Italian expertsCristina Chimenti, Patrizia Nencini, Federico Pieruzzi, et al.
Advances in Therapy|December 5, 2024
Effects of Current Therapies on Disease Progression in Fabry Disease: A Narrative Review for Better Patient Management in Clinical PracticeRenzo Mignani, Elena Biagini, Vittoria Cianci, et al.
Kidney International|April 17, 2004
Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot studyRenzo Mignani, Vincenzo Panichi, Antonio Giudicissi, et al.
The Journal of Vascular Access|August 12, 2009
Persistent left superior vena cava: what the interventional nephrologist needs to knowAntonio Granata, Simeone Andrulli, Fulvio Fiorini, et al.
NDT Plus|May 8, 2015
Isolated microalbuminuria as the first clinical presentation of Fabry disease in an adult heterozygous femaleRenzo Mignani, Paola Preda, Antonio Granata, et al.
Clinical Kidney Journal|December 11, 2025
Clinical outcomes in Fabry patients switching to agalsidase beta for renal ineffectiveness of the primary Fabry therapy: a single-centre analysisEleonora Riccio, Ivana Capuano, Pasquale Buonanno, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapyRenzo Mignani, Sandro Feriozzi, Roland M Schaefer, et al.
Frontiers in Medicine|February 26, 2021
Deficiency in the Screening Process of Fabry Disease: Analysis of Chronic Kidney Patients Not on DialysisYuri Battaglia, Fulvio Fiorini, Cristiano Azzini, et al.
Clinical Kidney Journal|September 29, 2016
FAbry STabilization indEX (FASTEX): an innovative tool for the assessment of clinical stabilization in Fabry diseaseRenzo Mignani, Federico Pieruzzi, Francesco Berri, et al.
American Journal of Nephrology|February 12, 2011
Assessment of kidney volume in polycystic kidney disease using magnetic resonance imaging without contrast mediumRenzo Mignani, Cristiana Corsi, Mariangela De Marco, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Orphanet Journal of Rare Diseases|April 9, 2020
The GALA project: practical recommendations for the use of migalastat in clinical practice on the basis of a structured survey among Italian expertsCristina Chimenti, Patrizia Nencini, Federico Pieruzzi, et al.
Advances in Therapy|December 5, 2024
Effects of Current Therapies on Disease Progression in Fabry Disease: A Narrative Review for Better Patient Management in Clinical PracticeRenzo Mignani, Elena Biagini, Vittoria Cianci, et al.
Kidney International|April 17, 2004
Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot studyRenzo Mignani, Vincenzo Panichi, Antonio Giudicissi, et al.
The Journal of Vascular Access|August 12, 2009
Persistent left superior vena cava: what the interventional nephrologist needs to knowAntonio Granata, Simeone Andrulli, Fulvio Fiorini, et al.
NDT Plus|May 8, 2015
Isolated microalbuminuria as the first clinical presentation of Fabry disease in an adult heterozygous femaleRenzo Mignani, Paola Preda, Antonio Granata, et al.
Clinical Kidney Journal|December 11, 2025
Clinical outcomes in Fabry patients switching to agalsidase beta for renal ineffectiveness of the primary Fabry therapy: a single-centre analysisEleonora Riccio, Ivana Capuano, Pasquale Buonanno, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapyRenzo Mignani, Sandro Feriozzi, Roland M Schaefer, et al.
Frontiers in Medicine|February 26, 2021
Deficiency in the Screening Process of Fabry Disease: Analysis of Chronic Kidney Patients Not on DialysisYuri Battaglia, Fulvio Fiorini, Cristiano Azzini, et al.
Clinical Kidney Journal|September 29, 2016
FAbry STabilization indEX (FASTEX): an innovative tool for the assessment of clinical stabilization in Fabry diseaseRenzo Mignani, Federico Pieruzzi, Francesco Berri, et al.
American Journal of Nephrology|February 12, 2011
Assessment of kidney volume in polycystic kidney disease using magnetic resonance imaging without contrast mediumRenzo Mignani, Cristiana Corsi, Mariangela De Marco, et al.
Pageof 7